期刊文献+

基于高内涵分析技术的新型PPARα/γ双重激动剂C333H和P633H的肝细胞毒性初步研究 被引量:1

Cytotoxicity of PPARα/γ dual agonists C333H and P633H on HepG2 cells using high content analysis
原文传递
导出
摘要 目的基于建立的高内涵细胞多参数毒性分析方法,观察新型PPARα/γ双重激动剂C333H和P633H的HepG2肝细胞毒性,并初步探查其可能的损伤机制。方法在HepG2人肝癌细胞上,采用高内涵分析(HCA)技术,进行C333H和P633H的细胞毒性(细胞数量、核固缩、膜通透性、线粒体膜电位和细胞色素C),以及氧化应激和DNA损伤的多参数分析。结果 MTT法测得C333H和P633H抑制HepG2细胞增殖的IC50分别为(161.57±15.29)μmol/L和(101.08±17.58)μmol/L。HCA研究表明C333H在10~100μmol/L,P633H在3~30μmol/L显著降低膜通透性和线粒体膜电位;C333H在30~300μmol/L、P633H在10~100μmol/L浓度依赖性地降低细胞数量。至高浓度时,300μmol/L C333H和100μmol/L P633H进一步显著降低线粒体膜电位和细胞数量,显著增加核DNA及细胞色素C含量,显著减少核面积,此浓度下膜通透性和超氧化物歧化酶显著增加。结论 C333H在低于100μmol/L,P633H在低于30μmol/L时对HepG2肝细胞无明显的毒性反应;线粒体损伤、膜完整性破坏是两化合物引起细胞毒性反应的主要机制,其中线粒体损伤为毒性反应早期敏感性检测指标。此外,HCA法与MTT法在细胞增殖作用的分析上具有较好的一致性。 Objective To observe the hepatotoxicity of novel PPARα/γ dual agonists C333H and P633H on HepG2 cells using high content analysis(HCA),and to explore the characteristics of toxicity.Methods Multi-parameter analysis of cytotoxicity(cell number,pyknosis,membrane permeability,mitochondrial membrane potential and cytochrome C),oxidative stress and DNA damage of C333H and P633H was carried out on the human hepatoma cell line HepG2 cells by using HCA.Results The IC_50 of C333H and P633H on inhibiting the proliferation of HepG2 cells was(161.57±15.29) μmol/L and(101.08±17.58)μmol/L,respectively.HCA indicated that the membrane permeability and mitochondrial membrane potential were significantly decreased at the concentration of 10 to 100 μmol/L of C333H,and at 3 to 30 μmol/L of P633H.Reduction of the cell number in a concentration-dependent manner was observed in C333H(30 to 300 μmol/L) and P633H(10 to 100 μmol/L).300 μmol/L of C333H and 100 μmol/L of P633H led to a lower mitochondrial membrane potential and cell number,increased the content of nuclear DNA and cytochrome C,decreased the nuclear area.Meanwhile,the membrane permeability and manganese-containing superoxide dismutase were also significantly increased at this concentration.Conclusion The results indicated that C333H(100 μmol/L) and P633H(30 μmol/L) show no significant cytotoxicity on HepG2 cells.The damage to the mitochondrial and to the membrane integrity is the main mechanism of cytotoxicity,the former being an early sensitive index.Additionally,HCA and MTT methods show better consistency in the analysis of the impact on cellular proliferation.
出处 《军事医学》 CAS CSCD 北大核心 2011年第12期928-932,共5页 Military Medical Sciences
基金 国家"重大新药创制"科技重大专项资助项目(2009ZX09501-031)
关键词 高内涵分析 肝毒性 PPAR 新药筛选 high content analysis hepatotoxicity PPAR new drug screening
  • 相关文献

参考文献12

  • 1陈伟.新型PPAR激动剂P633和C333的药效评价及药理学作用机制研究[D]中国人民解放军军事医学科学院,中国人民解放军军事医学科学院2009.
  • 2周辛波.基于结构的PPARα/γ双重激动剂的设计、合成与筛选[D]沈阳药科大学,沈阳药科大学2005.
  • 3Dykens JA,Will Y.The significance of mitochondrial toxicity testingin drug development. Drug Discovery Today . 2007
  • 4Lang P,Yeow K,Nichols Ae,t al.Cellular imaging in drug discovery. Nature Reviews Drug Discovery . 2006
  • 5Lessman CA.The developing zebrafish(Danio rerio):a vertebratemodel for high-throughput screening of chemical libraries. BirthDefects Res C Embryo Today . 2011
  • 6Jaeschke H,Gores GJ,Cederbaum AI,et al.Mechanisms of hepatotoxicity. Toxicological Sciences . 2002
  • 7Braissant O,Foufelle F,Scotto C,et al.Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat. The Journal of Endocrinology . 1996
  • 8Desagher S,Martinou JC.Mitochondria as the central control point of apoptosis. Trends in Cell Biology . 2000
  • 9Wei Hu,John J Kavanagh.Anticancer therapy targeting the apoptotic pathway. Lancet Oncology,The . 2003
  • 10GIULIANO KA,HASKINS JR,TAYLOR DL.Advances in high content screening for drug discovery. Assay Drug Dev Technol . 2003

同被引文献9

引证文献1

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部